Sionna Therapeutics, Inc. (SION)
SION Stock Price Chart
Explore Sionna Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze SION price movements and trends.
SION Company Profile
Discover essential business fundamentals and corporate details for Sionna Therapeutics, Inc. (SION) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Feb 2025
Employees
41.00
Website
https://www.sionnatx.comCEO
Michael Cloonan
Description
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
SION Financial Timeline
Browse a chronological timeline of Sionna Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 10 Nov 2025
EPS estimate is -$0.52.
Earnings released on 11 Aug 2025
EPS came in at -$0.41 surpassing the estimated -$0.68 by +39.71%.
Earnings released on 12 May 2025
EPS came in at -$0.62 falling short of the estimated -$0.45 by -37.78%.
Earnings released on 20 Mar 2025
EPS came in at -$3.38 falling short of the estimated -$0.57 by -492.98%.
Earnings released on 27 Nov 2024
EPS came in at -$0.92 .
SION Stock Performance
Access detailed SION performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.